ONCY News and Press, Oncolytics Biotech Inc. From 12/31/19

Neovasc (NASDAQ: NVCN ) +121%   files U.S. application for Reducer. More news on: Neovasc Inc., FuelCell Energy, Inc., Sol-Gel Technologies Ltd., Stocks on the move, Read more ...

These 5 Penny Stocks Have Upcoming Milestones; How Will The Market React? This year was one to watch biotech penny stocks as a whole. We saw some of the most aggressive breakouts ever from many of these names. If you take a look at our article about penny stocks that crushed it in 2019 , yo...

Gainers: Savara (NASDAQ: SVRA )  +98% . More news on: Savara Inc., NIO Limited, Sol-Gel Technologies Ltd., Stocks on the move, Read more ...

Nano cap Oncolytics Biotech ( ONCY +37% ) is up on more than a 4x surge in volume. Shares have rallied  246%  since mid-December when the company announced that an abstract on new biomarker data on lead drug Reolysin (pelareorep) in pancreatic cancer patients will be presented ...

These Penny Stocks Returned Big Gains For Investors; Can They Keep Going? Over the years, many have found that penny stocks often end up creating fortunes for stock market participants. This is sometimes by chance but for the every-day trader, it involves a very specific strategy developed o...

Gainers:  China Rapid Finance (NYSE: XRF ) +142% . More news on: China Rapid Finance Limited, Liquidia Technologies, Inc., NewLink Genetics Corporation, Stocks on the move, Read more ...

These Penny Stocks Are Making New Highs For December 2019 Investing in penny stocks can often prove to be one of the best ways of making quick money from modest capital. Over the years, thousands of investors have successfully done just that. However, the task of finding the best penny stoc...

Gainers:  Kaixin Auto (NASDAQ: KXIN ) +32% . More news on: Kaixin Auto Holdings, NantKwest, Inc., Renewable Energy Group, Inc., Stocks on the move, Read more ...

SAN DIEGO, CA and CALGARY, AB / ACCESSWIRE / December 12, 2019 / Oncolytics Biotech ® Inc. (NASDAQ:ONCY)(TSX:ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced the acceptance of an abstract highlighting new biomarker data from the ...

December 9, 2019 Palm Beach, FL –December 9, 2019 – One of the latest market reports in the published by Credence Research, Inc. shows that the Multiple Myeloma Treatment market, which was valued at USD $8,398.3 Mn in 2016, is expected to reach USD $21,221.8 Mn ...